NVIDIA
NVDA
Adobe
ADBE
Tesla
TSLA
Netflix
NFLX
Qualcomm
QCOM
US Stock MarketDetailed Quotes
AXGN AxoGen
- 17.250
- +0.090+0.52%
Close Mar 14 16:00 ET
- 17.250
- 0.0000.00%
Post 17:22 ET
764.93MMarket Cap-75.00P/E (TTM)
17.996High17.170Low351.10KVolume17.340Open17.160Pre Close6.11MTurnover0.90%Turnover RatioLossP/E (Static)44.34MShares21.00052wk High7.36P/B671.51MFloat Cap5.55052wk Low--Dividend TTM38.93MShs Float56.850Historical High--Div YieldTTM4.81%Amplitude0.164Historical Low17.414Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
AxoGen Stock Forum
In reaction to earnings/guidance:
• $Silvergate Capital (SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen (AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $Novartis AG (NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...
No comment yet